Simbiosys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics…
Simbiosys
SimBioSys is a TechBio company focused on redefining precision medicine and revolutionizing patient care to defeat cancer. They leverage artificial intelligence, data science, and spatial biophysics…
TL;DR
Headquarters: Chicago-based
Core product: TumorSight — patient-specific 3D tumor visualizations for treatment planning
Technology: AI-driven biophysical modeling and spatial analytics (Computational Microscope)
Founded: 2017–2018 (company materials list both 2017 origin and 2018 founding year)
Series A: $15M announced Oct 26, 2021
Company Overview
Problem Domain
Precision oncology, tumor heterogeneity, surgical and treatment planning, biomarker discovery
Founded
2018
Industry
Biotechnology
Funding Track Record
$15,000,000
Round announced Oct 26, 2021; reported as $15M
Investor Signal
“Genoa Ventures; Northpond Ventures; participation from AV8 Ventures, Heritage Medical Group, Mayo Clinic”
Founders
What we do
Join the Team
En la vacante como instaladore técnico te ofrecemos:
-Capacitación pagada
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |